Skip to main content

Rhythm Pharmaceuticals, Inc 10-Q for FY2026 Q2

Rhythm Pharmaceuticals, Inc. (RYTM)

10-Q 2026-08-04 For: 2026-06-30
View Original
Added on August 04, 2026

About this 10-Q

Rhythm Pharmaceuticals, Inc filed this 10-Q on August 4, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).

Headline figures

Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$71.26M
up 46.9% from $48.5M a year earlier
Net loss
$49.3M
compared with a net loss of $46.63M a year earlier
Diluted EPS
-$0.73
compared with -$0.75 a year earlier